Comprehensive Analysis of Factors Associated with New Episode of Postoperative Atrial Fibrillation after Coronary Artery Bypass Graft Surgery

por Rubanenko, Olesya, Rubanenko, Anatoly, Davydkin, Igor
Publicado 2023

Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab

por Kulagin, Alexander D., Ptushkin, Vadim V., Lukina, Elena A., Davydkin, Igor L., Korobkin, Alexander V., Shamrai, Vladimir S., Konstantinova, Tatyana S., Kaporskaya, Tatyana S., Mitina, Tatyana A., Ksenzova, Tatyana I., Zuev, Evgeny V., Markova, Oksana A., Gapchenko, Elena V., Kudlay, Dmitry A.
Publicado 2021

Biosimilar erythropoietin in anemia treatment (BEAT)—Efficacy and safety of a 1:1 dose conversion from EPREX(®) to EPIAO(®) in patients with end-stage renal disease on hemodialysis...

por Miao, Bolong, Isachkina, Alina Nikolaevna, Shutov, Evgeny Viktorovich, Selyutin, Alexander Alekseevich, Kvitkova, Lyudmila Vladimirovna, Shilo, Valery Yuryevich, Vetchinnikova, Olga Nikolaevna, Alexandrov, Ilya Vyacheslavovich, Perlin, Dmitry Vladislavovich, Zuev, Alexander Vasilievich, Davydkin, Igor Leonidovich, Mironova, Tatyana Pavlovna, Solovyova, Olga Mikhailovna, Tutin, Alexey Pavlovich, Omelchenko, Alexey Mikhailovich, Vareesangthip, Kriengsak, Khadikova, Nadezhda Georgievna, Li, Man, Li, Xiang
Publicado 2022